Showing results (131-140 of 252) with videos related to
Sort By:
Pageof 26
Future Oncology (London, England)|November 19, 2025
Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed IDH1 mutant AMLSamantha Nier, Jana Pelouchova, Ralph Hills, et al.Future Oncology (London, England)|November 16, 2025
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed IDH1 mutant acute myeloid leukemiaParesh Vyas, Sam Salek, Susana Vives, et al.Leukemia Research|July 1, 2015
The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatmentJuan-Manuel Sancho, Olga García, Santiago Mercadal, et al.British Journal of Haematology|June 26, 2014
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow TransplantationLuciana Tucunduva, Annalisa Ruggeri, Guillermo Sanz, et al.Journal of Hematology & Oncology|September 1, 2018
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabineFederica Giannotti, Myriam Labopin, Roni Shouval, et al.Haematologica|July 20, 2004
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocolAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.Leukemia & Lymphoma|April 29, 2016
Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-Maria Ribera, Mireia Morgades, et al.Blood Advances|June 8, 2022
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García-Calduch, Jordi Ribera, et al.European Journal of Haematology|November 27, 2019
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutionsSantiago Mercadal, Juan-Manuel Sancho, Fina Climent, et al.Haematologica|April 12, 2003
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 studyAlbert Oriol, Josep-Maria Ribera, Jordi Esteve, et al.Pageof 26